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Abstract
The CA1 region of the hippocampus plays a critical role in spatial and contextual memory, and has well-
established circuitry, function and plasticity. In contrast, the properties of the flanking CA2 pyramidal neurons
(PNs), important for social memory, and lacking CA1-like plasticity, remain relatively understudied. In particular,
little is known regarding the expression of voltage-gated K (Kv) channels and the contribution of these channels
to the distinct properties of intrinsic excitability, action potential (AP) waveform, firing patterns and neurotrans-
mission between CA1 and CA2 PNs. In the present study, we used multiplex fluorescence immunolabeling of
mouse brain sections, and whole-cell recordings in acute mouse brain slices, to define the role of heterogeneous
expression of Kv2 family Kv channels in CA1 versus CA2 pyramidal cell excitability. Our results show that the
somatodendritic delayed rectifier Kv channel subunits Kv2.1, Kv2.2, and their auxiliary subunit AMIGO-1 have
region-specific differences in expression in PNs, with the highest expression levels in CA1, a sharp decrease at
the CA1-CA2 boundary, and significantly reduced levels in CA2 neurons. PNs in CA1 exhibit a robust contribution
of Guangxitoxin-1E-sensitive Kv2-based delayed rectifier current to AP shape and after-hyperpolarization po-
tential (AHP) relative to that seen in CA2 PNs. Our results indicate that robust Kv2 channel expression confers a
distinct pattern of intrinsic excitability to CA1 PNs, potentially contributing to their different roles in hippocampal
network function.
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Significance Statement
CA1 and CA2 pyramidal neurons (PNs) play distinct roles in hippocampal network function. Determining the
molecular mechanisms that regulate excitability of CA1 versus CA2 PNs is important in understanding their
distinct plasticity, and their different roles in spatial and contextual versus social memory, respectively.
Here, we show that specific characteristics of action potential (AP) firing properties in CA1 versus CA2 PNs
can be attributed to voltage-gated K (Kv)2 channels, with higher expression levels and functional
contributions in CA1 versus CA2. Our results suggest that Kv2 channel expression is an important
determinant of specific aspects of AP firing properties in CA1 versus CA2 PNs, and that regulation of
membrane excitability by Kv2 channels may contribute to the robust synaptic plasticity of CA1 PNs.
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Introduction
Possibly the most studied neurons in the brain, CA1
pyramidal neurons (PNs) receive and integrate input from
area CA3 along their dendritic arbor, and then communi-
cate information to cortical and subcortical regions. The
CA1 region is a major component of the hippocampal
tri-synaptic circuit and allows the formation of spatial and
contextual memory. In contrast, the role of region CA2
has been more difficult to decipher. In vivo studies have
demonstrated that CA2 PNs do not encode spatial infor-
mation in the same way as CA3 and CA1 (Mankin et al.,
2015). CA2 PNs are necessary for social recognition
memory (Hitti and Siegelbaum, 2014; Stevenson and
Caldwell, 2014) and act to control hippocampal excitabil-
ity on a global scale (Boehringer et al., 2017). Moreover,
CA2 PNs form the crux of a hippocampal-wide network
that encodes spatial information during immobility (Kay
et al., 2016). Molecular profiling studies have identified
distinct mRNA expression patterns across the CA regions
in the hippocampus, clearly demonstrating the sharp bor-
der that exists between CA1 and CA2 that is detectible
with a growing number of molecular markers (Talley et al.,
2001; Lein et al., 2004; Lein et al., 2005). However, little is
known of the expression levels of voltage-gated K (Kv)
channels, the key determinants of intrinsic excitability,
action potential (AP) wave form, firing patterns, and neu-
rotransmission between CA1 and CA2 PNs.
The Kv2 family of Kv channels, which includes the
Kv2.1 and Kv2.2 principal or  subunits, and the AMIGO-1
auxiliary subunit, are abundantly expressed in the soma,
proximal dendrites and axon initial segment of many
types of brain neurons (Trimmer, 1991; Maletic-Savatic
et al., 1995; Kuja-Panula et al., 2003; Rhodes et al., 2004;
King et al., 2014; Mandikian et al., 2014; Bishop et al.,
2015). In the hippocampus, CA1 PNs express high levels
of Kv2 channels (Maletic-Savatic et al., 1995; Rhodes
et al., 2004; Speca et al., 2014; Bishop et al., 2015), which
underlie 60–80% of the delayed rectifier current re-
corded from PN somata (Murakoshi and Trimmer, 1999;
Du et al., 2000; Liu and Bean, 2014). In CA1 PNs, studies
using antisense oligonucleotide knockdown approaches
(Du et al., 2000) or employing the selective Kv2 blocking
neurotoxin Guangxitoxin-1E or GxTX (Liu and Bean, 2014)
showed that Kv2 channels contribute to controlling the
excitability of CA1 PNs. These channels, with their rela-
tively slow activation kinetics (Guan et al., 2007), regulate
repetitive firing, AP width and trough voltage after a spike.
The regulation of membrane excitability by these channels
likely contributes to the robust synaptic plasticity of CA1
PNs.
Clearly, regions CA1 and CA2 are distinct, with con-
trasting molecular compositions and roles in hippocampal
function. However, many questions remain concerning
the significance of the distinct molecular profiles across
areas CA1 and CA2. Given the dynamic regulation of Kv2
channels, and their pertinence in disease (Torkamani
et al., 2014; Thiffault et al., 2015) and their influence on
neuronal and behavioral excitability (Speca et al., 2014), a
detailed understanding of their expression across regions
of the hippocampus, and how this impacts cellular excit-
ability, would further our understanding of hippocampal
function. In the present study we used antibodies against
the CA2 PN marker RGS14, an accepted molecular
marker for CA2 PNs (Lee et al., 2010; Kohara et al., 2014),
and genetically encoded Amigo-2/Cre mice expressing
GFP in CA2 PNs (Hitti and Siegelbaum, 2014), with a
panel of highly validated Kv2 channel subunit antibodies
in multiplex fluorescence immunohistochemistry experi-
ments on mouse brain sections to determine the cellular
expression of Kv2 channel principal and auxiliary subunit
polypeptides across hippocampal regions CA1 and CA2.
We combined this with electrophysiological studies on the
role of Kv2 channel function on AP characteristics in CA1
versus CA2 PNs by blocking Kv2 channels with GxTX, a
selective blocker of Kv2 channels.
Materials and Methods
Antibodies
See details of antibodies used on Table 1.
C57/BL6J mice
All procedures involving C57/BL6J mice were approved
by the University of California Davis Institutional Animal
Care and Use Committee and were performed in strict
accordance with the Guide for the Care and Use of Lab-
oratory Animals of the NIH. All C57/BL6J mice were main-
tained under standard light-dark cycles and allowed to
feed and drink ad libitum. C57BL/6J were purchased from
The Jackson Laboratory (RRID:IMSR_JAX:000664). Both
male and female 12-week-old C57BL/6J were used.
Preparation of C57/BL6J mouse brain sections for
immunohistochemistry
Eight adult C57/BL6J mice (four females and four
males) were deeply anesthetized with 90 mg/kg Na-
pentobarbital salt (Sigma) in 0.9% NaCl solution through
intraperitoneal injections, followed by boosts as needed.
Once mice were completely anesthetized, they were tran-
scardially perfused with a brief prefix wash with 4.5 ml of
ice cold PBS [150 mM NaCl, 10 mM sodium phosphate
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buffer (PB), pH 7.4] containing 10 U/ml heparin, followed
by an ice-cold fixative solution of 4% formaldehyde
(freshly prepared from paraformaldehyde) in 0.1 M sodium
PB, pH 7.4, using a volume of 1 ml fixative solution per
gram of mouse weight. Following perfusions, brains were
removed from the skull and cryoprotected in 10% su-
crose, 0.1 M PB overnight at 4°C, then transferred to a
solution of 30% sucrose, 0.1 M PB until they sank to the
bottom of the tube (24–48 h). Following cryoprotection, all
brains were frozen, and cut on a freezing stage sliding
microtome (Richard Allen Scientific) to obtain 30-m-thick
sections. Sections were collected in 0.1 M PB and pro-
cessed for immunohistochemistry as free-floating sections.
Amigo-2/Cre mice
All procedures involving Amigo-2/Cre mice were ap-
proved by the Institutional Animal Care and Use Commit-
tee at Columbia University and the New York State
Psychiatric Institute. Amigo-2/Cre mice were main-
tained as hemizygotes on the C57BL/6J background.
Three male and three female 8-week-old mice were
used for stereotaxic injections. GFP expression in CA2
neurons was achieved by stereotaxic injection of a Cre-
dependent adeno-associated virus (AAV) expressing
eGFP into Amigo-2/Cre mice, as previously described
(Hitti and Siegelbaum, 2014). The AAV2/5-hSyn-DIO-
eGFP-WPRE-hGH virus was obtained from the University
of Pennsylvania Vector Core. In brief, for stereotaxic sur-
gery mice were anesthetized with continuous isoflurane
delivery. Temperature and anesthesia depth were monitored
periodically. To target CA2, mice were injected bilaterally
with 180 nl of virus at coordinates 1.6 AP, 1.6 ML, 1.7
DV or1.7 AP,1.9 ML,1.8 DV relative to bregma using
a Nanoject II (Drummond Scientific) auto-nanoliter injec-
tor. Mice recovered for three weeks to allow for adequate
viral expression. Mice were then deeply anesthetized with
isoflurane (5%) and perfused transcardially with 4.5 ml
ice-cold 0.1 M PBS buffer followed by 4% formaldehyde
(freshly prepared from paraformaldehyde) in PBS, using a
volume of 1 ml fixative solution per gram of mouse weight.
After decapitation, brains were removed and cryopro-
tected in 30% sucrose in 0.1 M PBS overnight at 4°C
before freezing.
Multiplexed fluorescence immunohistochemistry
Multiplex immunofluorescence labeling of mouse brain
sections was performed essentially as described (Man-
ning et al., 2012). In brief, free-floating sections were
washed 3 in 0.1 M PB and 10 mM sodium azide at room
temperature with slow agitation. All subsequent incuba-
tions and washes were at room temperature with slow
agitation. Sections were incubated in blocking buffer
(10% goat serum in 0.1 M PB, 0.3% Triton X-100, and 10
mM sodium azide) for 1 h. Immediately after blocking,
sections were incubated with primary antibody combina-
tions (diluted in blocking buffer) for 2 h. Following incu-
bation, sections were washed 3  10 min each in 0.1 M
PB, and incubated for 1 h with affinity-purified goat anti-
rabbit and/or goat anti-mouse IgG-subclass-specific
secondary antibodies conjugated to Alexa Fluors (Ther-
moFisher) and diluted in blocking buffer. Sections were
labeled with the DNA-specific dye Hoechst 33258 during
the secondary antibody step. After 3  10 min washes in
0.1 M PB, sections were mounted and dried onto gelatin-
coated slides, treated with 0.05% Sudan Black (EM Sci-
ences) in 70% ethanol for 1.5 min (Schnell et al., 1999),
extensively washed in water, and mounted with Prolong
Gold (ThermoFisher). All immunolabeling reported is rep-
resentative of at least five animals (biological replicates),
unless otherwise noted. Brain sections from all biological
replicates within each experiment were labeled, treated,
and mounted in parallel.
Table 1. Antibodies used in this study
Antibody name Species/isotype/immunogen Manufacturer information Concentration used
AMIGO-1, anti-AMIGO-1
rabbit pAb
Raised against aa 394–492 of mouse AMIGO-1
(cytoplasmic C-terminus).
Trimmer Lab. Rabbit 28330 RRID:AB_2571515 1:400 dilution of affinity purified
pAb, concentration unknown
L98/12, anti-AMIGO-1
mouse IgG1 mAb
Raised against aa 28–370 of mouse AMIGO-1
(extracellular N-terminus).
Trimmer lab.
RRID:AB_2571516
1:3 dilution of tissue culture
supernatant, concentration
unknown
K89/34, anti-Kv2.1
mouse IgG1 mAb
Raised against aa 837–853 of rat Kv2.1. Trimmer lab. NeuroMab catalog 73-014
RRID:AB_10672253
5 g/ml purified mAb
L61C/30, anti-Kv2.1
mouse IgG1 mAb
Raised against aa 595–616 of rat Kv2.1. Trimmer lab. RRID:AB_2532100 1:5 dilution of tissue culture
supernatant, concentration
unknown
N372B/1, anti-Kv2.2
mouse IgG1 mAb
Raised against aa 717–907 of rat Kv2.2. Binds
within aa 764–907. Species reactivity with
mouse, rat, ferret, macaque and human
NeuroMab catalog 73–369, RRID:AB_2315869 1:3 dilution of tissue culture
supernatant, concentration
unknown
N372B/60, anti-Kv2.2
mouse IgG2b mAb
Raised against aa 717–907 of rat Kv2.2. Binds
within aa 764–907. Species reactivity with
mouse and rat
NeuroMab catalog 73–360, RRID:AB_2315867 1:10 dilution of tissue culture
supernatant, concentration
unknown
N372C/51, anti-Kv2.2
mouse IgG1 mAb
Raised against aa 717–907 of rat Kv2.2. Binds
within aa 717–763 Species reactivity with
mouse and rat
NeuroMab catalog 73–358, RRID:AB_2315865 1:2 dilution of tissue culture
supernatant, concentration
unknown
N133/21, anti-RGS14
mouse IgG2a mAb
Raised against aa 1–544 of rat RGS14. NeuroMab catalog 73–170,
RRID:AB_10698026
1:10 dilution of tissue culture
supernatant, concentration
unknown
Details of the polyclonal (pAb) and monoclonal (mAb) Abs used in this study.
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Imaging and image analysis
All images were acquired on a Zeiss AxioObserver Z1
microscope with an X-Cite 120 lamp as the fluorescent
light source and equipped with an AxioCam MRm digital
camera. Low-magnification wide-field imaging was done
using a 10/0.5 NA Fluar objective, and images were
reconstructed as tiled mosaics using Axiovision 4.8.2 ac-
quisition software (Carl Zeiss MicroImaging, RRID: Sci-
Res_000111). High-magnification optical sections were
acquired using an ApoTome structured illumination sys-
tem (Carl Zeiss MicroImaging) with a 63/1.40 NA plan-
Apochromat oil immersion objective. ApoTome z-stacks
were acquired and processed with Axiovision 4.8.2 acqui-
sition software (Carl Zeiss MicroImaging, RRID: Sci-
Res_000111). All brain sections within a given experiment
and immunolabeled with the same antibody cocktail were
imaged under the same conditions (objective, exposure
time, lamp settings, etc.). Image processing was per-
formed in Axiovision (Carl Zeiss MicroImaging), ImageJ
(NIH) and MATLAB (MathWorks). All panels in a given
figure were imaged and treated identically, unless other-
wise noted. Low-magnification wide-field mosaics and
high-magnification ApoTome z-stacks were opened for
analysis as raw image files in ImageJ (NIH) using the
Bio-Formats library importing plugin (Linkert et al., 2010).
All statistical analyses of immunolabeling were performed
in Prism (GraphPad).
Linescans were used to measure labeling intensity
across the different regions of CA (CA1 to CA2 to CA3) in
low-magnification (10) mosaic images of hippocampus.
Linescans were 18 m (28 pixels) thick, and data points
reflected the mean intensity values (mean of 28 pixels) per
area unit. Linescans were drawn across CA1 to CA2 to
CA3 in stratum pyramidale (s.p.). Values from multiple
immunolabels and of Hoechst dye were simultaneously
measured from the same linescan. Background levels for
individual labels were measured from no primary controls
and mathematically subtracted from linescan values.
Intensity values for each linescan and for individual
antibody labels were normalized to their own average
intensity in the CA region with the highest level of immu-
nolabeling. Linescans from different brain sections (and
from different animals) were aligned based on RGS14
labeling and the normalized values across different lines-
cans were averaged. Mean fluorescence intensity values
in high-magnification (63) images were quantified by
ROI selections. Individual neurons were identified by
Hoechst staining. CA2 PNs were identified by RGS14
labeling. ROI selections were drawn in single optical sec-
tions, which show signal from only one neuronal layer in
the Z plane. Each ROI was drawn around the Kv2-labeled
area clearly seen in the periphery of the neurons using the
“polygon selection tool” in ImageJ. Intensity values were
normalized to the average value of CA1 neurons.
Electrophysiology slice preparation
C57BL/6J mice were housed and euthanized in accor-
dance with Université Paris Descartes ethics committee
approval. C57BL/6J male mice (8–10 weeks old) were
anesthetized with ketamine/xylazine and isoflurane. Mice
were intracardially perfused with oxygenated cutting so-
lution containing 93 mM NMDG, 2.5 mM KCl, 1.25 mM
NaH2PO4, 30 mM NaHCO3, 20 mM HEPES acid, 25 mM
glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-
pyruvate, 0.5 mM CaCl2, 10 mM MgCl2, and 93 mM HCl.
Hippocampi were removed and placed upright into an
agar mold and 400-m-thick transverse slices were cut
with a vibratome (Leica VT1200S) in ice-cold solution and
transferred to 30°C ACSF (125 mM NaCl, 2.5 mM KCl, 10
mM glucose, 26 mM NaHCO3, 1.25 mM NaH2PO4, 2 mM
Na pyruvate, 2 mM CaCl2, and 1 mM MgCl2) for 30 min
and kept at room temperature for at least 1.5 h before
recording. Cutting and recording solutions were both sat-
urated with 95% O2 and 5% CO2, pH 7.4.
Electrophysiological recordings and analysis
Whole-cell recordings were obtained with an Axon
700B amplifier and Digidata 200 ADDA converter (Molec-
ular Devices). A slice scope (Scientifica) equipped with an
IR LED and Dodt contrast was used to visualize the slices,
which were held into the recording chamber with a plati-
num and nylon harp. ACSF was perfused through the
recording chamber at 3 ml/min. All experiments were
performed at 33°C. Recordings were performed with a
patch pipette (3 M pipette resistance) containing 135
mM K-methylsulfate, 5 mM KCl, 0.1 mM EGTA-Na, 10
mM HEPES, 2 mM NaCl, 5 mM MgATP, 0.4 mM Na2GTP,
10 mM Na2 phosphocreatine, and 5 M biocytin (pH 7.2;
280–290 mOsm). The liquid junction potential was 2 mV
and membrane potentials were corrected post hoc. Series
resistance (typically 12–15 M) was carefully monitored in
voltage clamp mode by the application of a 100-ms
5-mV step. The membrane resistance (RM), membrane
capacitance (CM) and resting membrane potential (RMP)
were measured for each cell within 5 min after break-in. In
current clamp, the amplifier circuitry (Axon 700B, Molec-
ular Devices) was used to compensate the bridge bal-
ance, which was carefully monitored during experiments.
Cells with 10% change in series resistance or leak were
excluded from analysis. For all experiments involving
measurements of AP firing, current was injected to keep
the membrane potential at70 mV for both CA1 and CA2
PNs. GxTX (Smartox Biotechnology) was dissolved in
0.1% BSA and aliquoted as 100 M stocks. Aliquots were
promptly thawed before use and predissolved in ACSF
before bath application. For every cell that we recorded,
we allowed the cell’s intrinsic properties to stabilize and
then waited 9 2 min before applying GxTX. Before GxTX
application, we performed the recording protocol every 2
min to measure AP firing properties to ensure that cell
firing was not changing with time. Changes in CA1 PN
firing properties were seen within 4 min of GxTX applica-
tion. However, all recordings from GxTX-treated CA1 and
CA2 PNs were performed 8 min after GxTX application to
ensure the completeness of the effect of the toxin. We
used pClamp10 software for data acquisition and Ax-
ographX and Origin Pro for data analysis and statistical
testing. All analyses of AP shape and after-hyperpo-
larization potential (AHP) were performed as described by
Liu and Bean (Liu and Bean, 2014). For both CA1 and CA2
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PNs, the AHP was quantified by measuring the most
hyperpolarized potential between APs. Statistical com-
parisons were performed using Student’s t test, two-way
ANOVA with repeated measure when appropriate. Results
are reported as mean  SEM.
Results
Abrupt changes in Kv2 channel subunit expression
at the CA1-CA2 boundary
Previous immunohistochemistry studies have de-
scribed the expression patterns of the Kv2.1 and Kv2.2 
subunits in regions CA1 and CA3 of rodent hippocampus
(Hwang et al., 1993; Maletic-Savatic et al., 1995; Sarmiere
et al., 2008; Kirizs et al., 2014; Mandikian et al., 2014), and
have noted high-level expression of Kv2.1 in CA1 PNs
relative to CA3. However, these studies did not specifi-
cally address the expression of Kv2 channel subunits
across the boundary between regions CA1 and CA2.
To determine the relative expression of Kv2.1, Kv2.2,
and their auxiliary subunit AMIGO-1 in region CA1 versus
CA2, we used multiplex fluorescence immunohistochem-
istry to label brain sections from C57BL/6J mice with
KO-validated antibodies against the individual members
of the Kv2 family (Mandikian et al., 2014; Bishop et al.,
2015) together with markers for region CA2, including a
monoclonal antibody against the CA2-specific marker
RGS14 (Lee et al., 2010; Kohara et al., 2014). As shown in
Figure 1, immunolabeling for each of the Kv2 channel 
and AMIGO-1 auxiliary subunit antibodies exhibits a sub-
stantial reduction in labeling intensity at or near CA1-CA2
boundary, delineated by RGS14 labeling. We next ex-
tended these observations to determine how expression
varies across the full extent of regions CA1, CA2, and CA3
of mouse hippocampus. Images representative of those
used for quantitation are shown in Figure 1A, and the
quantification of fluorescence intensity determined by li-
nescans across s.p. of CA1-CA3 is shown in Figure 1B. As
previously reported, RGS14 labeling is concentrated in
the relatively small area between regions CA1 and CA3
(Lee et al., 2010; Kohara et al., 2014). This RGS14-positive
CA region is characterized by large cell bodies and lower
neuronal density that typifies CA2 (Lorente de Nó, 1934).
Kv2.1 immunolabeling is highest in s.p., in accordance
with its restricted subcellular localization on the soma,
Figure 1. The distribution of Kv2 channel  and auxiliary subunit immunolabeling in s.p. changes at the CA1-CA2 boundary, and again
within region CA3 of mouse hippocampus. A, Representative low-magnification (10, wide-field mosaic) images of C57BL/6J mouse
coronal brain sections immunelabeled for combinations of Kv2.1, Kv2.2, AMIGO-1, and the CA2 marker RGS14. Arrowheads indicate
the boundaries of region CA2 based on RGS14 immunolabeling. Scale bar, 500 m. B, Quantification of mean fluorescence intensity
from linescans across s.p. of regions CA1, CA2, and CA3. Values are normalized to the maximum average intensity (n 	 8 mice).
New Research 5 of 12
July/August 2017, 4(4) e0267-17.2017 eNeuro.org
proximal dendrites and axon initial segment. The highest
Kv2.1 immunolabeling intensity corresponds to region
CA1, with a pronounced decrease at the CA1-CA2 boun-
dary, as demarcated by the site of the sharp increase in
RGS14 labeling (Fig. 1). The lower immunolabeling levels
of Kv2.1 in CA2 were preserved across CA3 (Fig. 1).
Immunolabeling for the Kv2.2  subunit was also highest
in CA1 and dropped sharply at the CA1-CA2 border.
Similar to the pattern seen for Kv2.1 and Kv2.2, immuno-
labeling for the AMIGO-1 auxiliary subunit also decreased
at the CA1-CA2 boundary (Fig. 1). Qualitatively similar
results were obtained with independent antibodies with
distinct binding sites on each Kv2 channel subunit (data
not shown), supporting that these patterns of immunola-
beling were reflective of differences in expression levels
and not immunoreactivity, per se. In contrast to Kv2.1,
Kv2.2, and AMIGO-1 exhibited a graded expression
across region CA3 (Fig. 1), with lower labeling in distal
CA3 (nearest CA2) and higher immunolabeling in proximal
CA3 (toward the dentate gyrus).
The density of PNs decreases substantially moving
from CA1 to CA2 (Lorente de Nó, 1934). In our experi-
ments, we found that the density of Hoechst nuclear
labeling is indeed lower in CA2 compared to CA1. As
such, it is possible that the differences in the overall
intensity of immunolabeling for Kv2 channel subunits seen
at the CA1-CA2 border is simply a reflection of the lower
density of PNs in CA2, as opposed to lower expression of
these Kv2  and auxiliary subunits in individual PNs of
region CA2. To address this, we next performed high-
magnification imaging with optical sectioning to define the
immunolabeling on a cell-by-cell basis, and determine
differences in expression between RGS14 positive and
negative neurons within the CA regions. As shown in the
representative images depicted in Figure 2A, the RGS14
negative PNs in CA1 proper and at the CA1-CA2 bound-
ary have the highest labeling intensity for Kv2.1, Kv2.2,
and AMIGO-1, whereas RGS14 positive neurons within
the CA1-CA2 boundary zone, and within CA2 proper,
have relatively low levels of such immunolabeling. The
differences in immunolabeling intensities observed be-
tween CA1 and CA2 PNs are statistically significant as
seen by the quantification of fluorescence intensity per-
formed on individual PNs (Fig. 2B). Similar to what is seen
in the low-magnification images, region CA3 contains
neurons that have a lower intensity of Kv2.1 immunola-
beling than seen in CA1, but with levels of Kv2.2 and
AMIGO-1 immunolabeling in proximal CA3 approaching
those seen in CA1 (Fig. 2A).
To confirm results obtained using RGS14 immunolabel-
ing to define region CA2, we next used the distinct CA2
marker AMIGO-2. Amigo-2/Cre mice expressing GFP in
CA2 PNs (Hitti and Siegelbaum, 2014) were used to dis-
tinguish CA2 PNs. Brain sections from these mice were
immunolabeled for Kv2.1, Kv2.2, or AMIGO-1, as well as for
RGS14. Figure 3A shows representative low-magnification
images of the hippocampus that show a high degree of
concordance between GFP-positive and RGS14-positive
neurons, as was previously demonstrated for this transgenic
mouse line (Hitti and Siegelbaum, 2014). The overall pattern
of Kv2.1, Kv2.2, and AMIGO-1 immunolabeling in brain sec-
tions from these mice (Fig. 3) is indistinguishable from that
seen in C57BL/6Jmice (Fig. 1). Moreover, the CA2 boundary
demarcated by GFP expression corresponds well to the
region in which the differences in Kv2.1, Kv2.2, and
AMIGO-1 immunolabeling differ across the CA regions.
Higher magnification imaging with optical sectioning in the
CA1-CA2 boundary region revealed lower levels of Kv2
channel subunit immunolabeling in individual GFP-positive
PNs than in GFP-negative neurons (Fig. 3B). These obser-
vations were comparable to those seen when RGS14 im-
munolabeling was used to define CA2 neurons in C57BL/6J
mice. Taken together, these results show that the expres-
sion of Kv2  and auxiliary subunits drops sharply at the
CA1-CA2 border, and remains low throughout CA2 com-
pared to CA1. Moreover, they show that Kv2.2 and
AMIGO-1, but not Kv2.1, exhibit a gradual increase in CA3,
with higher levels of expression in proximal versus distal
CA3.
Kv2 channels play a prominent role in determining
AP properties in CA1 but not CA2 PNs
Our immunolabeling results indicate that the expression
levels of Kv2 channel subunits are substantially lower in
CA2 PNs relative to those in CA1. A previous study in
acutely dissociated mouse CA1 neurons demonstrated
that selectively blocking Kv2 channels with 100 nM GxTX
blocks 60–80% of delayed rectifier currents, and alters
initial firing frequency and AHP trough (Liu and Bean,
2014). Here, based on the expression analyses above, we
performed a comparison of Kv2 channel function in CA1
versus CA2 neurons. We performed electrophysiology on
acute mouse hippocampal slices and recorded from CA1
and CA2 PNs in whole-cell current clamp mode, before
and after bath application of 100 nM GxTX. We first
validated the use of GxTX application in acute hippocam-
pal slices. Changes in CA1 PN firing properties were seen
within 4 min of GxTX application. However, all recordings
from GxTX-treated CA1 and CA2 PNs were performed 8
min after GxTX application to ensure the completeness of
the effect of the toxin. We demonstrated that in this
preparation, GxTX application has a similar effect on CA1
PN AP firing properties that has previously been de-
scribed in acutely dissociated mouse neurons (Liu and
Bean, 2014). While we did not detect a significant in-
crease in the first AP width following block of Kv2 chan-
nels, we observed a significant increase in the width of the
second AP (Fig. 4). Furthermore, the block of Kv2 chan-
nels resulted in a significant increase in the AHP trough
potential following both the first and second APs (Fig. 4).
We postulated that because our immunolabeling exper-
iments reveal a sharp drop in immunolabeling intensity for
Kv2  and auxiliary subunits at the CA1-CA2 border, CA2
PNs likely do not express substantial levels of Kv2 chan-
nels relative to CA1 PNs. Thus, the application of GxTX
application would have little or no effect on CA2 PN AP
firing properties. We tested this hypothesis by performing
whole-cell current clamp recordings in both CA1 and CA2
PNs. As shown in Table 2, the CA1 and CA2 PNs in our
slice preparations exhibited a difference, while not signif-
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Figure 2. Individual CA2 PNs have reduced levels of Kv2 channel  and auxiliary subunit immunolabeling compared to CA1 neurons.
A, High-magnification (63) representative images of C57BL/6J mouse coronal brain sections immunolabeled for Kv2.1, Kv2.2,
AMIGO-1, and RGS14. Single optical z-section images (ApoTome Zeiss). Scale bar, 35 m. B, Quantification of mean fluorescence
intensity from ROIs corresponding to individual RGS14  and RGS14 – PNs. Values are normalized to average values in CA1 PNs.
(n 	 4 mice). Error bars show SEM. Asterisks denote samples exhibiting significant differences (p 
 0.001, unpaired t test).
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icant, in RMPs (p 	 0. 2), and significant differences in RM
(p 	 0.04), and CM (p 	 0.03), consistent with what has
been previously described (Chevaleyre and Siegelbaum,
2010). Thus, to determine what effect GxTX application
had on AP shape and membrane excitability, we first
determined the AP threshold and injected 1-s-long steps
of depolarizing current (Fig. 5). While we consistently saw
an increase in AP width in CA1 PNs for the 2nd AP, we
never observed such a change in AP shape in CA2 PNs.
Furthermore, when examining changes in AHP trough
following GxTX application, we consistently observed a
substantial change in the minimal potential of the AHP
trough on GxTX treatment in CA1 PNs, but no change in
CA2 PNs (Fig. 5C), even following injections of current 300
pA over AP threshold.
We also examined the change in AP width and AHP
trough as a function of AP number before and after ap-
plication of GxTX for CA1 and CA2 PNs. For CA1 PNs,
there is a consistent increase in AP width for the second
and subsequent APs (Fig. 6A,B), whereas for CA2 PNs, no
significant change was observed following GxTX applica-
tion. Likewise, we observed a consistent increase in AHP
trough for all APs measured in area CA1 following GxTX
application, but no effect in area CA2 (Fig. 6C). Lastly, we
examined how blockade of Kv2 current by GxTX applica-
tion altered the instantaneous firing frequency of CA1 and
CA2 PNs. We found that when comparing the instanta-
neous frequency of the first two APs, application of GxTX
significantly increased the AP firing frequency between
the first and second APs in CA1 PNs (control: 34.6  4.0
Hz, GxTX: 40.8  3.8, n 	 6, p 	 0.03). This is consistent
with the change in AHP trough that we observe, indicating
that Kv2 channels are active in controlling the initial burst
firing and membrane excitability in CA1 PNs (Fig. 6D).
When considering the dynamic firing properties of CA1
PNs, we found that blocking Kv2 channels in CA1 PNs
increases adaptive AP firing (Fig. 6F), and could prevent
AP firing following 800 ms of current injection (Fig. 6A).
Figure 3. Amigo-2/Cre GFP-positive CA2 PNs have reduced levels of Kv2 channel  and auxiliary subunit immunolabeling. A,
Representative low-magnification (10, wide-field mosaic) images of Amigo-2/Cre mice expressing GFP in CA2 PNs. Coronal brain
sections from five mice were immunolabeled for Kv2.1, Kv2.2, AMIGO-1, and RGS14. Scale bar, 500 m. B, High-magnification (63)
representative images of Amigo-2/Cre mice expressing GFP in CA2 PNs. Single optical z-sections images (ApoTome Zeiss) were
obtained from five Amigo-2/Cre mice immunolabeled for Kv2.1, Kv2.2, AMIGO-1, and RGS14. Scale bar, 35 m.
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In contrast, we observed no detectible effect on CA2 PN
instantaneous frequency following application of GxTX
(Fig. 6E,G). Together, these results show that Kv2 chan-
nels play a prominent role in determining the firing prop-
erties of CA1 but not CA2 PNs.
Discussion
Delayed rectifier Kv channels of the Kv2 family are
expressed in PNs in s.p. of the hippocampus (Hwang
et al., 1993; Maletic-Savatic et al., 1995; Kuja-Panula
et al., 2003; Mandikian et al., 2014). The studies presented
here showed substantial differences in expression of Kv2
channel  and auxiliary subunits precisely at the CA1-CA2
boundary, with much lower levels in s.p. of CA2 compared
to those in CA1. We show that these lower levels of
immunolabeling are not simply due to the lower cell den-
sity in CA2 versus CA1, but are reflective of differences in
immunolabeling for these Kv2 channel subunits within
individual CA2 PNs, as quantified using high-magni-
fication optical section imaging. The difference in the
levels of Kv2 channel immunolabeling in CA1 versus CA2
PNs was observed in brain tissue from both C57BL/6J
and Amigo-2/Cremice. That similar results were obtained
with at least two monoclonal antibodies with independent
non-overlapping binding sites on each subunit, and also
with polyclonal antibody preparations, strongly supports
that this immunolabeling reflects the levels of expression
of the individual subunits in these neurons. The cellular
pattern of immunolabeling obtained here is generally con-
sistent with previously published immunolabeling results,
and with in situ hybridization studies posted by the Allen
Brain Atlas. However, our results provide higher resolution
information that this change in Kv2 channel subunit ex-
pression occurs precisely at the CA1:CA2 boundary,
which these other sources could not provide due to the
lack of specific molecular definition of region CA2.
Figure 4. GxTX effects on AP characteristics in CA1 PNs. Bath
application of 100 M GxTX altered the AP shape and AHP of
CA1 PNs. A, Example traces of an AP in a CA1 PN as recorded
in whole-cell current clamp configuration in response to a current
injection of 260 pA before (black) and after (red) the application
of 100 nM GxTX. B, Summary graph showing the measured AP
widths for the 1st and 2nd AP before and after the application of
GxTX. Gray symbols are individual cells, black is the mean. C,
Summary graph showing the minimum AHP trough potential
following the 1st and 2nd AP before and after GxTX application.
Gray, individual points, black, mean. Error bars show SEM.
Table 2. Intrinsic membrane properties of CA1 and CA2 PNs
PN type RMP (mV) RM (M) CM (pF)
CA1 (N 	 6) 70.2  1.3 84.8  13.8 151.4  38.6
CA2 (N 	5) 73.1  1.6 49.1  3.7 316.3  56.3
Figure 5. GxTX has different effects on CA1 and CA2 PN AP
properties. A, Example traces from CA1 and CA2 PNs recorded
in whole-cell current clamp mode in response to current injec-
tions of different duration and amplitude before (black) and after
(gray) the application of 100 nM GxTX. B, Summary graph
showing the change in AP width following GxTX application as a
function of current injection over threshold for CA1 (red) and CA2
(black) PNs. Data are presented for both the 1st and 2nd AP. C,
Summary graph of the change in minimal potential of the AHP
trough following GxTX application as a function of current injec-
tion for the 1st and 2nd AP.
New Research 9 of 12
July/August 2017, 4(4) e0267-17.2017 eNeuro.org
Consistent with these immunolabeling results is the
overall lack of an effect of GxTX on AP characteristics in
CA2 PNs, relative to the robust and diverse effects of this
neurotoxin on APs in CA1 neurons. The results presented
here, obtained from CA1 PNs in intact hippocampal slice
preparations, are in good agreement with previous results
from acutely dissociated CA1 neurons (Liu and Bean,
2014). Our results demonstrate a prominent role for Kv2
channels in CA1 PNs, where they are highly expressed on
the soma, proximal dendrites, and axon initial segment, in
determining membrane excitability, and the shape and
frequency of APs. In contrast, we show that unlike in CA1
PNs, APs in CA2 PNs lack any demonstrable response to
GxTX treatment, consistent with the significantly reduced
expression of Kv2 channels observed in these PNs rela-
tive to those in CA1. CA2 PNs are distinct in lacking the
afterhyperpolarizing trough seen in CA1 neurons (Cheva-
leyre and Siegelbaum, 2010), a characteristic that has
been attributed to Kv2 channels (Liu and Bean, 2014). The
substantially reduced expression of Kv2 channels likely
confers a distinct input-output relationship to CA2 neu-
rons, that, when combined with their unique network
connectivity, would underlie their fundamentally different
function in hippocampal information processing.
Our experiments show that Kv2 currents clearly con-
tribute to the AP width and AHP of CA1 PNs. Thus, in CA1
PNs, by controlling the AP width, these channels are likely
acting to control neuronal excitability during periods of
high activity by limiting calcium influx during AP firing, as
has been demonstrated in hippocampal slice cultures
Figure 6. GxTX has different effects on repetitive firing in CA1 versus CA2 PNs. A, Example traces from CA1 and CA2 PNs recorded
in whole-cell current clamp mode in response to a 1-s long current injection of 460 pA before (black) and after (orange) the application
of 100 nM GxTX. Note how GxTX altered several properties of CA1 PN AP firing but had little to no effect on CA2 PNs. B, Summary
graph showing the change in AP width with GxTX application as a function of AP number. Note the consistent change in AP width
in CA1 whereas no increase was observed with CA2. C, Summary graph of the change in minimal potential of the AHP trough
following GxTX application as a function of AP number. D, The instantaneous frequency of AP firing in CA1 PNs before (open circles)
and after (closed circles) the application of GxTX. The block of Kv2 channels significantly increased the instantaneous frequency of
the first two APs, but had no significant effect on the subsequent instantaneous firing frequencies. E, The instantaneous frequency
of AP firing in CA2 PNs before (open circles) and after (closed circles) the application of GxTX. F, The instantaneous frequency
normalized to the first AP, to illustrate the changes in adaptive AP firing for CA1 PNs before (open circles) and after (closed circles)
the application of GxTX. Current injection step was around 300 pA over AP threshold. G, Summary graph of the normalized
instantaneous frequency for CA2 PNs before (open circles) and after application of GxTX (filled circles) as a function of AP number.
Current injection step was 500 pA over AP threshold. Error bars show SEM.
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treated with antisense oligonucleotides targeting Kv2.1
(Du et al., 2000). Presynaptic neurotransmitter release
paired with AP firing is a central component of long-term
potentiation (Magee and Johnston, 1997). By their contri-
bution to the AHP, we postulate that Kv2 currents may be
contributing to CA1 PN repetitive firing and induction of
long-term plasticity, as indicated by intact acute slice
recordings of the scaeffer-collateral-CA1 synapse in Kv2.1
knockout mice (Speca et al., 2014). Thus, these channels
both prevent hyperexcitability while simultaneously permit-
ting plasticity in region CA1, a hippocampal area well estab-
lished to central for memory formation and learning.
In contrast, it has been demonstrated by multiple
groups that CA2 PNs are highly resistant to postsynaptic
long-term potentiation (Zhao et al., 2007; Chevaleyre and
Siegelbaum, 2010). While the consequence of this lack of
plasticity in CA2 PNs is not fully understood, differences
in intracellular signaling cascades (Lee et al., 2010) as well
as calcium buffering (Simons et al., 2009) have been
proposed to underlie this unusual property. Furthermore,
differences in expression of numerous ion channels, in-
cluding the absence of Kv2 channels, gives CA2 PNs very
different properties compared to neighboring CA1. For
instance, CA2 PNs have more hyperpolarized membrane
potential and much lower RM that CA1 PNs, likely due to
the expression of voltage-gated and leak channels, mak-
ing these cells less excitable than CA1 PNs in general. The
integrative properties of CA2 PN dendrites have shown to
be unique, allowing the propagation of distal dendritic
input in a manner that is strikingly different from CA1 (Sun
et al., 2014; Srinivas et al., 2017). It is clear that in vivo,
CA2 PNs do not behave like CA1 PNs, with rapidly re-
mapping place cells (Mankin et al., 2015) and the ability to
encode location during immobility (Kay et al., 2016). Thus,
there remains much to be learned about CA2 PN physi-
ology and function.
We also note that there is a gradient of Kv2.2 and
AMIGO-1, but not Kv2.1, from low in the distal region of
CA3 (adjacent to CA2) and progressively higher toward
the proximal region of CA3 (closer to the dentate gyrus).
The elevated expression of Kv2.2, but not Kv2.1, in prox-
imal CA3 may confer on these neurons properties distinct
from distal CA3 and CA2, which lack prominent Kv2
channel expression, and CA1, which expresses high lev-
els of both Kv2.1 and Kv2.2. This may impact the plastic-
ity of Kv2 channel function in these neurons, given the
robust phosphorylation-dependent regulation of Kv2.1
but not Kv2.2 (Bishop et al., 2015). Gradients in gene
expression, connectivity and functionality across CA3
have been reported (Li et al., 1994; Thompson et al., 2008;
Nakamura et al., 2013). Several Kv channels, such as
Kv3.1, Kv3.2, Kv4.3, Kv5.1, and Kv10.1 have been shown
to have a gradient of expression across CA3 at the mRNA
level (Vega-Saenz de Miera, 2004; Thompson et al., 2008).
The differences in ion channel expression across region
CA3 presumably support the observed differences in in-
trinsic excitability and firing patterns in distal versus prox-
imal CA3 PNs (Bragdon et al., 1986). Future studies
employing GxTX may be useful to defining the specific
role of the gradient of Kv2.2-containing delayed rectifier
channels in these differences across region CA3, as
shown here for the distinctions between PNs in regions
CA1 and CA2.
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